abraxane-Injection  

The US Food and Drug Administration (FDA) today approved nanoparticle albumin-bound (nab)-paclitaxel (Abraxane, Celgene), in combination with gemcitabine, for the first-line treatment of metastatic pancreatic cancer.

文章標籤

快樂小藥師 發表在 痞客邦 留言(1) 人氣()